InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Barinthus Biotherapeutics plc.

BRNS Clue Score36
United States Fiscal year ends December CIK 0001828185
$0.74 +0.00% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.74 −94.85% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 30 Apr 2021. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2020Revenue4.8Operating income−20.0Net income−17.7EPS, diluted−2.24Fiscal year 2021Revenue0.3 −94.4%Operating income−45.2Net income−50.9EPS, diluted−1.96Fiscal year 2022Revenue44.7 +16,580.2%Operating income−4.0Net income5.3EPS, diluted0.14Fiscal year 2023Revenue0.8 −98.2%Operating income−83.9Net income−73.3 −1,473.0%EPS, diluted−1.91Fiscal year 2024Revenue15.0 +1,766.5%Operating income−68.0Net income−61.1EPS, diluted−1.55Fiscal year 2025Revenue0.0 −100.0%Operating income−70.6Net income−66.4EPS, diluted−1.64
FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 4.8 0.3 44.7 0.8 15.0 0.0
Growth −94.4% +16,580.2% −98.2% +1,766.5% −100.0%
Operating income −20.0 −45.2 −4.0 −83.9 −68.0 −70.6
Net income −17.7 −50.9 5.3 −73.3 −61.1 −66.4
Growth −1,473.0%
EPS, diluted −2.24 −1.96 0.14 −1.91 −1.55 −1.64

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2020Operating margin−415.8%Net margin−367.3%Free cash flow margin−234.8%Fiscal year 2021Operating margin−16,873.5%Net margin−18,979.5%Free cash flow margin−12,585.4%Fiscal year 2022Operating margin−9.0%Net margin11.9%Free cash flow margin−46.0%Fiscal year 2023Operating margin−10,463.1%Net margin−9,145.5%Free cash flow margin−7,024.7%Fiscal year 2024Operating margin−454.1%Net margin−408.0%Free cash flow margin−199.3%Fiscal year 2025
FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −415.8% −16,873.5% −9.0% −10,463.1% −454.1% n/a
Net margin −367.3% −18,979.5% 11.9% −9,145.5% −408.0% n/a
Free cash flow margin −234.8% −12,585.4% −46.0% −7,024.7% −199.3% n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2020Operating cash flow−11.0Capital expenditure−0.3Free cash flow−11.3Fiscal year 2021Operating cash flow−32.6Capital expenditure−1.1Free cash flow−33.7Fiscal year 2022Operating cash flow−14.4Capital expenditure−6.1Free cash flow−20.6Fiscal year 2023Operating cash flow−50.9Capital expenditure−5.4Free cash flow−56.3Fiscal year 2024Operating cash flow−28.9Capital expenditure−0.9Free cash flow−29.8Fiscal year 2025Operating cash flow−48.0Capital expenditure−0.0Free cash flow−48.0
FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −11.0 −32.6 −14.4 −50.9 −28.9 −48.0
Capital expenditure −0.3 −1.1 −6.1 −5.4 −0.9 −0.0
Free cash flow −11.3 −33.7 −20.6 −56.3 −29.8 −48.0
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2020Cash43.3Shareholders’ equity−36.9Fiscal year 2021Cash214.1Shareholders’ equity252.1Fiscal year 2022Cash194.4Shareholders’ equity242.9Fiscal year 2023Cash142.1Shareholders’ equity186.8Fiscal year 2024Cash110.7Shareholders’ equity130.0Fiscal year 2025Cash70.5Shareholders’ equity74.2
FY2020FY2021FY2022FY2023FY2024FY2025
Cash 43.3 214.1 194.4 142.1 110.7 70.5
Shareholders’ equity −36.9 252.1 242.9 186.8 130.0 74.2

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2020 31 Dec 2020 FY2021† 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
4.8 0.3 44.7 0.8 15.0 0.0
Growth −94.4% +16,580.2% −98.2% +1,766.5% −100.0%
14.4 20.4 42.4 44.9 42.2 25.6
10.5 25.1 6.4 39.8 29.7 40.8
−20.0 −45.2 −4.0 −83.9 −68.0 −70.6
Growth
n/a −51.1 0.9 −76.5 −61.2 −66.6
0.1 −0.0 −4.5 −3.1 −0.0 −0.2
−17.7 −50.9 5.3 −73.3 −61.1 −66.4
Growth −1,473.0%
Per share
−2.24 −1.96 0.14 −1.91 −1.55 −1.64
−2.24 −1.96 0.14 −1.91 −1.55 −1.64
Growth −1,464.3%
7.9 25.9 37.2 38.4 39.3 40.5
7.9 25.9 38.2 38.4 39.3 40.5
Growth +227.6% +47.4% +0.6% +2.5% +3.0%

† The diluted share count jumps at 2021, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 5 of 6 years on file.